11:10 AM EST, 02/04/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were higher late Tuesday morning, rising 0.50% to 1,356.26 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by biotech firm Evaxion Biotech ( EVAX ) , which soared 36.3%, followed by biopharmaceutical company DBV Technologies ( DBVT ) , which rose 10%. They were followed by financial services companies Banco Bilbao Vizcaya Argentaria ( BBVA ) and Banco Santander (SAN), which were up 3.3% and 3.6%, respectively.

The decliners from continental Europe were led by medical device maker EDAP TMS ( EDAP ) , which fell 1.2%, followed by consumer goods company Unilever ( UL ) and pharmaceutical company Novo Nordisk ( NVO ) , which were down 0.4% and 0.1% respectively.

From the UK and Ireland, the gainers were led by Akari Therapeutics ( AKTX ) and biopharmaceutical companies TC Biopharm ( TCBP ) , which rose 5.9% and 3.3% respectively. They were followed by biopharmaceutical companies Mereo BioPharma Group ( MREO ) and Verona Pharma ( VRNA ) , which increased 2% and 1% respectively.

The decliners from the UK and Ireland were led by telecommunications operator Vodafone ( VOD ) and biopharmaceutical company NuCana ( NCNA ) , which dropped 5% and 3.4% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) , which lost 0.2%.